| Mon, Dec 7, 2009 | | • | Phase IIa Clinical Data Confirms Potential of Allon's Davunetide as a Treatment for Cognitive Impairment in Schizophrenia Patients
CCNMatthews (Mon, Dec 7)
| | Tue, Nov 17, 2009 | | • | Allon Chosen as "Top 10 Partnering Candidate" and Presenting at Major Partnership Conference
CCNMatthews (Tue, Nov 17)
| | Tue, Nov 10, 2009 | | • | Allon Therapeutics Releases Third Quarter Operating Results
CCNMatthews (Tue, Nov 10)
| | Thu, Oct 29, 2009 | | • | Allon CEO to Present at Bio Investor Forum and Bio Europe Conferences
CCNMatthews (Thu, Oct 29)
| | Thu, Oct 8, 2009 | | • | Canadian Patent Strengthens IP for Allon's 2nd Technology Platform
CCNMatthews (Thu, Oct 8)
| | Wed, Sep 9, 2009 | | • | Allon CEO to Present at Rodman and Renshaw Annual Global Investment Conference
CCNMatthews (Wed, Sep 9)
| | Thu, Sep 3, 2009 | | • | Alzheimer's Therapeutics Reviewed by NeuroInvestment
Marketwire (Thu, Sep 3)
| | Wed, Aug 12, 2009 | | • | Allon CEO to Present at Canaccord Adams Global Growth Conference
CCNMatthews (Wed, Aug 12)
| | Tue, Aug 11, 2009 | | • | Allon CEO to Present at Canaccord Adams Global Growth Conference
CCNMatthews (Tue, Aug 11)
| | Mon, Aug 10, 2009 | | • | Allon Therapeutics Releases Second Quarter Operating Results
CCNMatthews (Mon, Aug 10)
| | Thu, Jul 9, 2009 | | • | Allon Releases Results of Phase II Schizophrenia Cognitive Impairment Clinical Trial
CCNMatthews (Thu, Jul 9)
| | Thu, Jun 25, 2009 | | • | Allon Therapeutics Forms Steering Committee for Phase II Human Trial
CCNMatthews (Thu, Jun 25)
| | Tue, Jun 9, 2009 | | • | Allon CEO to Present at Noble Financial Investment Conference
CCNMatthews (Tue, Jun 9)
| | Thu, May 28, 2009 | | • | Allon Receives Notice of Allowance From European Patent Office for Lead Compound Davunetide (NAP) as Alzheimer's Treatment
CCNMatthews (Thu, May 28)
| | Thu, May 14, 2009 | | • | Allon Therapeutics Releases First Quarter Operating Results
CCNMatthews (Thu, May 14)
| | Tue, Apr 14, 2009 | | • | Allon Therapeutics Inc.: Issued U.S. Patent Strengthens IP for Allon Technology Platform
CCNMatthews (Tue, Apr 14)
| | Tue, Mar 17, 2009 | | • | Allon CEO to Present at Cowen and Company Investment Conference
CCNMatthews (Tue, Mar 17)
| | Thu, Mar 12, 2009 | | • | Allon Presents Data at Alzheimer's/Parkinson's Conference in Prague Confirming the Potential of Davunetide Intranasal (AL-108) to Treat Frontotemporal Dementia
CCNMatthews (Thu, Mar 12)
| | Mon, Mar 9, 2009 | | • | Allon Reports 2008 Audited Operating Results and Updates 2009 Plans
CCNMatthews (Mon, Mar 9)
| | Mon, Feb 9, 2009 | | • | Allon's CEO Presenting at BIO CEO Conference in NYC
CCNMatthews (Mon, Feb 9)
|
Add NPC.TO News to My Yahoo!:
 
| |
|
0.83% Nasdaq 
0.005 (1.67%) 
Headlines
